Pediatric multisystem inflammatory syndrome (MIS-C) associated with COVID-19 in a child from the Western Amazon (Atena Editora)

Abstract

Goal: Contribute to the knowledge of medical society by identifying the disease and understanding its importance, especially from the point of view of clinical and laboratory diagnosis, with emphasis on clinical manifestations. Methods: The proposed study is a case report, observational and descriptive, developed at Hospital Pronto Socorro da Criança Zona Sul, started in February 2021. The instruments used to collect information were anamnesis and physical examination. during the period in which the patient remained hospitalized in the referred hospital unit - by means of a medical record review. The observation and discussion of the case in the service's multidisciplinary meetings were also part of the data acquisition. The completion of the collection of information took place through the acquisition of secondary data with continuous review of the medical record and photographic record of the diagnostic methods to which the patient was submitted and literature review (until October 18, 2022 in the databases of the PubMed/MedLine with the keywords of this work). All records and information obtained were duly explained and requested from the patient's legal guardian, who by mutual agreement and non-profit signed a free and informed consent form (ICF). Experience report: To reinforce, through a case report, the importance of the clinical manifestations and complementary tests of MIS-C in a child from the Western Amazon and to describe the treatment instituted and the recommended clinical follow-up. Conclusion: Pediatric multisystem inflammatory syndrome was reported in Brazil during the second wave of the COVID-19 pandemic and the importance of such a serious disease requires studies and publications of similar cases in order to identify the factors involved in the etiology of the disease and create a database for correlations of cases and treatments instituted.